Changes in symptoms of anhedonia with psilocybin-assisted psychotherapy: A secondary analysis of a randomized clinical trial for treatment-resistant depression

被引：0
|
作者：
Kaczmarek, Erica [1 ]
Rosenblat, Joshua [2 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
BIPOLAR DISORDERS | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P77
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [31] Treatment-resistant depression with anhedonia: Integrating clinical and preclinical approaches to investigate distinct phenotypes
    Kelly, Chris A.
    Freeman, Kevin B.
    Schumacher, Julie A.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2022, 136
  • [32] Analysis of Clinical Trial Exit Interview Data in Patients with Treatment-Resistant Depression
    Sandy Lewis
    Carla Romano
    Geert De Bruecker
    James W. Murrough
    Richard Shelton
    Jaskaran B. Singh
    Carol Jamieson
    The Patient - Patient-Centered Outcomes Research, 2019, 12 : 527 - 537
  • [33] Analysis of Clinical Trial Exit Interview Data in Patients with Treatment-Resistant Depression
    Lewis, Sandy
    Romano, Carla
    De Bruecker, Geert
    Murrough, James W.
    Shelton, Richard
    Singh, Jaskaran B.
    Jamieson, Carol
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2019, 12 (05): : 527 - 537
  • [34] A statistical analysis plan for a randomized clinical trial to evaluate the efficacy and safety of ethosuximide in patients with treatment-resistant depression
    Jiang, Jiajun
    Wang, Zheng
    Dong, Yiyan
    Yang, Yan
    Ng, Chee H.
    Ma, Shuangshuang
    Xu, Yi
    Hu, Hailan
    Hu, Shaohua
    MEDICINE, 2019, 98 (31)
  • [35] Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
    Jared Kopelman
    Timothy A. Keller
    Benjamin Panny
    Angela Griffo
    Michelle Degutis
    Crystal Spotts
    Nicolas Cruz
    Elizabeth Bell
    Kevin Do-Nguyen
    Meredith L. Wallace
    Sanjay J. Mathew
    Robert H. Howland
    Rebecca B. Price
    Translational Psychiatry, 13
  • [36] Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
    Kopelman, Jared
    Keller, Timothy A.
    Panny, Benjamin
    Griffo, Angela
    Degutis, Michelle
    Spotts, Crystal
    Cruz, Nicolas
    Bell, Elizabeth
    Do-Nguyen, Kevin
    Wallace, Meredith L.
    Mathew, Sanjay J.
    Howland, Robert H.
    Price, Rebecca B.
    TRANSLATIONAL PSYCHIATRY, 2023, 13 (01)
  • [37] PSILOCYBIN FOR TREATMENT-RESISTANT MAJOR DEPRESSION - RESULTS FROM AN ACADEMIC PHASE 2B RANDOMIZED-CONTROLLED TRIAL
    Mertens, Lea Julia
    Koslowski, Michael
    Brand, Manuela
    Evens, Ricarda
    Kaertner, Laura
    Majic, Tomislav
    Scharf, Dennis
    Spangemacher, Moritz
    Wolff, Max
    Gruender, Gerhard
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 462 - 463
  • [38] Psilocybin for Treatment-Resistant Major Depression - Results From an Academic Phase 2b Randomized-Controlled Trial
    Mertens, Lea Julia
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 12 - 12
  • [39] Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis
    Fang, Qiwen
    Chan, Vivien Kin Yi
    Chan, Sandra Sau Man
    Jiao, Yuanshi
    Wang, Jiaqi
    Li, Xue
    PSYCHIATRY RESEARCH, 2024, 337
  • [40] Predictors of Treatment Response in Patients with Treatment-Resistant Depression: Outcomes of a Randomized Trial
    Khalid, Karniza
    Ang, Wei Chern
    Nazli, Aimi Izwani Mohd.
    Jamaluddin, Ruzita
    Rizvi, Syed A. A.
    PSYCHIATRY INTERNATIONAL, 2023, 4 (03): : 246 - 254
12345